Időskori makuladegeneráció: vizsgálatok itt: Dél-Korea

In Dél-Korea 9 Also abroad 220

9 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Daegu, Gyeonggi-do, Seoul
Életkor
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
No phaseTaking people
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Where
Seoul
Életkor
50 év and over
People
1000 worldwide
Run by
University of Wisconsin, Madison
See details and how to joinNCT06924021
3. fázisFut, nem toboroz
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Daegu, Seogu, Seongnam-si, Seoul
Életkor
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
4. fázisTaking people
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
Where
Seongnam, Seoul
Életkor
50 év and over
People
64
Run by
Junyeop Lee
See details and how to joinNCT07367282
No phaseNot yet taking people in Dél-Korea
Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration
Where
Ansan, Seoul
Életkor
50 év and over
People
40
Run by
Nu Eyne Co., Ltd.
See details and how to joinNCT07700147
3. fázisTaking people
Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
Where
Seoul
Életkor
50 év and over
People
266
Run by
SANGMYUNG innovation
See details and how to joinNCT07695207
3. fázisTaking people
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Where
Daegu
Életkor
50 év and over
People
50
Run by
Yeungnam University College of Medicine
See details and how to joinNCT07461441
4. fázisNot yet taking people in Dél-Korea
Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
Where
Seoul
Életkor
50 év and over
People
30
Run by
Kim's Eye Hospital
See details and how to joinNCT07187804
No phaseTaking people
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Where
Daegu
Életkor
20 év to 80 év
People
100
Run by
Kyungpook National University Hospital
See details and how to joinNCT02026843